Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study

T.F.V. van Haaps*, D. Collard, F.H.M.V. van Osch, S. Middeldorp, M. Coppens, M.D. de Kruif, E.A. Vlot, R.A. Douma, H. ten Cate, N.P. Juffermans, N. Gritters, A.P. Vlaar, A.C. Reidinga, M.A. Heuvelmans, M. Oudkerk, H.R. Buller, J.P.W.V. van den Bergh, A. Maas, M. Ten Wolde, S. SimsekM. Beudel, N. van Es, Corona Research Fund Amsterdam UMC, Dutch COVID & Thrombosis Coalition

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)35-38
Number of pages4
JournalThrombosis Research
Publication statusPublished - 1 Dec 2021


  • COVID-19
  • Thrombosis
  • Anticoagulants
  • SARS-CoV-2
  • Mortality

Cite this